Vimta Labs Limited (NSE:VIMTALABS)
1,018.15
+19.25 (1.93%)
May 2, 2025, 3:29 PM IST
Vimta Labs Revenue
Vimta Labs had revenue of 899.23M INR in the quarter ending December 31, 2024, with 10.09% growth. This brings the company's revenue in the last twelve months to 3.53B, up 9.87% year-over-year. In the fiscal year ending March 31, 2024, Vimta Labs had annual revenue of 3.19B with 0.08% growth.
Revenue (ttm)
3.53B
Revenue Growth
+9.87%
P/S Ratio
6.41
Revenue / Employee
2.47M
Employees
1,428
Market Cap
22.64B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 3.19B | 2.43M | 0.08% |
Mar 31, 2023 | 3.19B | 402.99M | 14.46% |
Mar 31, 2022 | 2.79B | 677.23M | 32.09% |
Mar 31, 2021 | 2.11B | 298.68M | 16.49% |
Mar 31, 2020 | 1.81B | -318.29M | -14.94% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |
Vimta Labs News
- 5 months ago - Vimta Labs shares surge 34% in past one month - Business Upturn